Web Date: June 7, 2006
FDA Approves Resumed Sale Of MS Drug
A multiple sclerosis (MS) drug withdrawn from the market for a year because of a rare but serious side effect will be allowed to return under a restricted distribution program designed to help ensure safe use of the product, federal health officials said on June 5.
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society